2026 ICD-10-CM Diagnosis Code Q53.212Bilateral inguinal testes

ICD-10-CM Codes›Q00-Q99›Q50-Q56›Q53

ICD-10-CM Q53.212
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

Q53.212 is a billable ICD-10-CM diagnosis code for bilateral inguinal testes. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 729 through 730. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Genitourinary congenital anomalies.

Code Identity

ICD-10-CM Code
Q53.212
Billable Status
Yes — Valid for Submission
Code Describes
Bilateral inguinal testes
Short Description
Bilateral inguinal testes
Same as the full description in the CMS dataset.
Parent Code
Q53.21
Abdominal testis, bilateral

Code Classification

ChapterQ00-Q99Congenital malformations, deformations and chromosomal abnormalities
SectionQ50-Q56Congenital malformations of genital organs
CategoryQ53Undescended and ectopic testicle
This CodeQ53.212Bilateral inguinal testes

Present on Admission (POA)Billing

Q53.212 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Inguinal
      • testicle
        • bilateral

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MAL003
Genitourinary congenital anomalies
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Birth Defects

A birth defect is a problem that happens while a baby is developing in the mother's body. Most birth defects happen during the first 3 months of pregnancy. One out of every 33 babies in the United States is born with a birth defect.

The full article covers:

  • What are birth defects?
  • What causes birth defects?
  • Who is at risk of having a baby with birth defects?
  • How are birth defects diagnosed?
  • What are the treatments for birth defects?
  • Can birth defects be prevented?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert Q53.212 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
752.51 Undescended testis
Approximate The match is approximate rather than exact.

Code History & ChangesHistory

Replacement Q53.212 replaces the following previously assigned code(s):

  • Q53.21 - Abdominal testis, bilateral
FY 2018AddedAdded to the ICD-10-CM code setEffective October 1, 2017.
FY 2019–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About Q53.212Overview

Is Q53.212 (Abdominal testis, bilateral) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report bilateral inguinal testes on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does Q53.212 group to?

When bilateral inguinal testes is the principal diagnosis on an inpatient stay, it groups to MS-DRG 729, 730, with relative weights from 0.6720 to 1.0587 depending on complications. Higher weights mean higher Medicare reimbursement.

Is Q53.212 exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for bilateral inguinal testes on inpatient claims.

What is the ICD-9 equivalent of Q53.212?

Under the General Equivalence Mappings, bilateral inguinal testes converts to ICD-9-CM 752.51 (undescended testis). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.